The search for new culture media that will encourage the growth and production of active antimicrobial metabolites by probiotics has become of utmost importance in the light of increasing bacterial resistance and the high costs of commercial media to cultivate the probiotics. Hence, the study was aimed at characterizing and determining the activity of metabolites obtained from Lactobacillus acidophilus strains cultivated in two novel media against pathogenic bacteria. Eight strains of L. acidophilus were cultivated in Morinda citrifolia juice and Glycine max extract. Bacterial metabolites were harvested and evaluated for antibacterial activity against two human pathogens, Staphylococcus aureus and Escherichia coli. All tested metabolites of L. acidophilus strains showed significant bactericidal activity, as indicated by zone of inhibition in the culture plates compared with control. There was a statistically significant difference in the activity of the metabolites against S. aureus and E. coli. Metabolites of L. acidophilus FTDC-4462 strain exhibited the highest zone of inhibition against S. aureus and E. coli in both growth media. Metabolites of L. acidophilus strains were more effective against S. aureus than E. coli. There were no significant differences in the growth media on antimicrobial effect of the metabolites of L. acidophilus against E. coli and S. aureus. Metabolites of L. acidophilus significantly inhibited the growth of both pathogenic bacteria used and can be used as potential antibiotic or probiotic agents. M. citrifolia juice and G. max extract could be used as novel and cheap culture media for L. acidophilus to produce antibacterial metabolites.
How to cite this article:
Hassan Pyar, Min-Tze Liong and K.K Peh, 2013. Characteristics and Antibacterial Activity of Metabolites from Lactobacillus acidophilus Strains Produced from Novel Culture Media. International Journal of Pharmacology, 9: 92-97.
Probiotics are live microorganisms, similar to symbiotic microorganisms which are found in the human gut (Saavedra, 2001; Douglas and Sanders, 2008) and act as beneficial microorganisms to humans when administered in adequate quantities. Probiotics serve as dietary supplements to enhance the growth and health of the host animals. Therefore, they have received increased attention as a means of disease control, digestion aids, immune booster and supplementing or replacing the use of antimicrobial compounds in the field of health and medicine (Chantharasophon et al., 2011). In addition, probiotic microorganisms have been used as a food preservative and antimicrobial agent more than other chemical agents due to the probiotic effects on human and other animal foods.
There is a growing interest among researchers to study the therapeutic effects of probiotics against various diseases such as chronic intestinal inflammatory disease (Mach, 2006), pathogen-induced diarrhea (Yan and Polk, 2006), urogenital infections (Reid, 2008) and atopic diseases (Vanderhoof, 2008). Probiotics in alimentary duct increases the immunological response (Hung et al., 2008) and reduces host cholesterol levels (Usman and Hosono, 2000). It has also showed significant beneficial effects compared with antibiotics or other medicines with no side effects, allergy, or toxicity. The best example of probiotics is breast milk, which develops the innate immunity of infants (NCCAM, 2008).
Metabolites derived from probiotics have strong bactericidal effects against food-borne pathogens (Yesillik et al., 2011), broad bacteriostatic effects on E. coli and S. aureus (Gharaei-Fathabad and Eslamifar, 2011) and antimicrobial agents for pathogenic bacteria such as E. coli, S. typhi, S. dysenteriae, B. anthracis and S. aureus (Amin et al., 2009).
Various types of microorganism strains have been employed for probiotic production (Heller, 2001; OMahony et al., 2005). Among these are Lactobacillus and Bifidobacterium (Critchfield et al., 2011), which have not shown any risk to humans (Saxelin et al., 1996; Naidu et al., 1999). A metabolite such as bacteriocin, isolated from lactic acid bacteria is one of the antimicrobial substances which is proteinaceous in nature and mostly acts against closely related species (Bali et al., 2011). However, the feed back regulation of bacteriocin is not clear. On the other hand, the bactericidal and inhibition effects depend on factors such as low pH, other organic acids, hydrogen peroxide (H2O2), ethanol and low oxidation-reduction (Pitt et al., 2000).
Generally, L. acidophilus has been grown in various media such as Man-Rogosa Sharpe (MRS) medium (De Man et al., 1960), Rogosa medium (Rogosa et al., 1951), Lactobacillus Selective (LBS) medium (Mitsuoka, 1978; Atlas, 1997) and Lactobacillus Anaerobic MRS with Vancomycin and Bromocresol green (LAMVAB) medium (Hartemink et al., 1997) for various fermentation processes and probiotic production. However, those commercially available media are expensive and this implies increased production cost as well as probiotic cost. To overcome the high production cost, there is need to find alternative natural sources of growth media with same probiotic nature as L. acidophilus (Naveena et aI., 2005; Shahravy et al., 2012).
Morinda citrifolia (noni) and Glycine max (soya bean) are traditional medicinal plants that have been extensively used in folk medicine by Polynesians for over 2000 years (Hirazumi et al., 1996). The plants have been reported to have a broad range of therapeutic and nutritional properties (Singh et al., 1984) including antibacterial, antiviral, antifungal, anticancer activities, analgesic, hypotensive, anti-inflammatory and immune enhancing effects (Selvam et al., 2009) in addition to being useful in treatment of liver and heart conditions (Wang et al., 2008).
So far, the utilization of noni juice and soya bean extract as alternative natural sources of growth media with the probiotics L. acidophilus has not been documented. Therefore, the main objective of the present study is to determine the bactericidal activity of metabolites isolated from L. acidophilus strains cultivated in M. citrifolia (noni) juice and G. max (soya bean) against two human pathogens, S. aureus (Gram positive) and E. coli (Gram negative).
MATERIALS AND METHODS
Microorganisms and culture media reagents: Man Rogosa Sharpe (MRS) broth was purchased form Hi-media, India. Nutrient agar and nutrient broth were purchased from Merck, Darmstadt, Germany. M. citrifolia (noni) and G. max (soya bean) were purchased from a local supplier in Penang, Malaysia.
Preparation of fermentation substrates
Preparation of M. citrofolia substrate: Freshly harvested ripe M. citrifolia fruits were collected from a local supplier in Penang, Malaysia in 2010. The fruits were thoroughly washed in lukewarm water to remove extraneous materials. The seeds were separated by manual splitting.
The M. citrifolia fruit juice was prepared with fruits and water (1:1). The juice was extracted using a juice squeezer and filtered through cheese cotton cloth, then stored at -20°C until use. The fresh juice of M. citrifolia was used for inoculation. Before inoculation, the pH of M. citrifolia juice was fixed at 6.5 using 1 M NaOH followed by sterilization for 15 min at 121°C.
Preparation of soy milk substrate: Dried soybeans (Glycine max) were purchased from a local supplier in Penang, Malaysia. They were soaked overnight to promote swelling and then blended with distilled water at a ratio of 1:6 (w/v). The blended mixture was filtered with muslin cloth and the resultant soy milk was pasteurized at 95°C for 15 min. The resultant milk was directly used for inoculation.
Test strains: The pathogenic microorganisms Staphylococcus aureus (Clinical isolate) and Escherichia coli (Clinical isolate) were collected from the Pathology Laboratory, General Hospital, Penang, Malaysia. The bacterial strains were cultivated in nutrient agar slants and preserved at 4°C.
Probiotics culture and growth conditions: Strains of L. acidophilus FTDC 2804, L. acidophilus FTDC 0785, L. acidophilus FTDC 8592, L. acidophilus FTDC 1295, L. acidophilus FTDC 4793, L. acidophilus FTDC 4462, L. acidophilus FTDC 0582 and L. acidophilus FTDC 2916 were obtained from culture Center of School of Industrial Technology, Universiti Sains Malaysia, Penang, Malaysia. The strains were cultivated in sterile MRS broth (dextrose 20.0 g L-1; meat peptone 10.0 g L-1; beef extract 10.0 g L-1; yeast extract 5.0 g L-1; sodium acetate 5.0 g L-1; disodium phosphate 2.0 g L-1; ammonium citrate 2.0 g L-1; tween 80 1.0 g L-1; magnesium sulfate 0.1 g L-1, manganese sulfate 0.05 g L-1) at 37°C for 36 h.
The broth was collected, centrifuged (5000 rpm) and washed three times to remove other substrates. The cells were re-suspended in M. citrifolia (noni) and G. max (soya bean) substrate (1% v/v inoculum size) and were incubated at 37°C for 36 h. After incubation, the bacterial suspension was centrifuged at 4°C for 15 min at 5000 rpm (Beckman, USA). The metabolites were evaluated for antimicrobial activity.
Evaluation of antibacterial activity: The antibacterial assay was quantified by modifying the well diffusion method assay procedure of Fooks and Gibson (2002) and Savadogo et al. (2004). The well diffusion method assay has been widely used to determine the bactericidal activity against different types of pathogenic microorganisms (Yesillik et al., 2011). The antimicrobial activities were determined by measuring the diameter of zone of growth inhibition formed around the wells. To confirm the bactericidal and bacteriostatic effects, swab was taken from the growth inhibition zone and then inoculated into nutrient broths and incubated at 37°C for 24 h and evaluated for growth.
Statistical analysis: The results were analyzed statistically using one-way analysis of variance (version 17.0, SPSS, USA). When there was a statistically significant difference, Post-hoc Tukeys fair Significant Difference test was applied. ANOVA data with p<0.001, p<0.01 and p<0.05 were classified as statistically significant.
The results of bacteriostatic and bactericidal properties of the metabolites of L. acidophilus strains cultivated from noni and soy-milk on the growth of S. aureus and E. coli are presented in Table 1. Results show that all of the probiotic strains grown in both culture media were able to inhibit the growth of E. coli and S. aureus. The results were expressed as Mean±SD, each data point is the average of measurement from six independent replicates, (n = 6). The results of the antibacterial activities of probiotic L. acidophilus strains cultivated in noni juice and soy-milk against S. aureus are given in Fig. 1. This clearly depicts the inhibition zones obtained in S. aureus culture in noni juice were in the range of 9.50-10.50 mm, while the inhibition zones observed in S. aureus cultures in soy-milk were 9.58- 10.43 mm.
|Table 1:||Antibacterial effect of probiotics from noni and soy-milk on the growth of S. aureus and E.coli|
|BS: Bacteriostatic, BC: Bactericidal|
|Fig. 1:||The antibacterial activities of probiotic L. acidophilus strains cultivated in noni juice and soy-milk against S. aureus. Values are Mean±SD (n = 6), **Significant when compared with the control (p<0.01), *Significant when compared to the control (p<0.01)|
The highest inhibition was obtained with L. acidophilus FTDC 4462 against S. aureus cultivated in noni juice with the inhibition zone 10.50 mm (p<0.01 ) and S. aureus cultivated in soy-milk with zone of inhibition 10.43 mm (p<0.01), while, the lowest inhibition effect was obtained with L. acidophilus FTDC 2804 against S. aureus cultivated in noni juice (9.50 mm) and L. acidophilus FTDC 2804 against S. aureus cultivated in soy-milk (9.58 mm) (Fig. 1).
This study shows that L. acidophilus is effective against E. coli and S. aureus and it could act as bactericidal agent against human pathogenic bacteria as the diameters of the inhibition zones were considerably high and significant. This suggests the potent bactericidal activity of M. citrifolia and G. max as natural substrates for L. acidophilus against the tested pathogenic bacteria. Figure 2 shows the antibacterial activities of probiotic L. acidophilus strains cultivated in noni juice and soy-milk against E. coli. The inhibition zones measured in E. coli cultures in noni juice were in the range of 9.37-10.84 mm, whereas, the inhibition zones found in E. coli cultures in soy-milk were in the range of 9.52-11.12 mm.
|Fig. 2:||The antibacterial activities of probiotic L. acidophilus strains cultivated in noni juice and soy-milk against E. coli. Values are Mean±SD (n = 6). **Significant when compared with the control (p<0.001), *Significant when compared to the control (p<0.01)|
The highest inhibition was obtained with L. acidophilus FTDC 4462 towards E. coli (10.84 mm) cultivated in noni juice and E. coli cultivated in soy-milk (11.12 mm). Lowest inhibition effect was noted with L. acidophilus 2804 against E. coli (9.37 mm) cultivated in noni juice and E. coli (9.52 mm) cultivated in soy-milk.
Selection of suitable probiotics starter from the natural source is a highly critical factor in the production of fermented products. Earlier studies (Eklund, 1989; Gan et al., 2002; Schillinger and Lucke, 1989; Tharmaraj and Shah, 2009) showed that the probiotics grown in MRS media exerted considerable antagonistic effect against the human pathogens B. cereus, L. monocytogenes, Methicillin Resistance S. aureus (MRSA) and P. aeruginosa, the causative agents of food borne diseases, listeriosis, skin infections and lung disease, respectively (Bhilabutra et al., 2007).
Overall results showed that the metabolites of all eight strains exerted considerable antibacterial effect, as the zone of inhibition results were significant when compared with the control. The growth media showed no significant influence on the antimicrobial effect of metabolites of strains L. acidophilus against E. coli and S. aureus, both growth media did not show any significant influence on the antimicrobial effect of metabolites of the strains. Staphylococcus aureus was more sensitive to the inhibitory substance produced by the L. acidophilus isolates than E. coli. Similar results have been reported by Toure et al. (2003) and Tadese et al. (2005). The resistance of Gram negative bacteria is attributed to the particular nature of their cellular envelops. According to Bhunia et al. (1991) bacteriocin produced by Lactobacillus strains interact with lipoteichoic acids that are absent in Gram-negative bacteria. On the other hand, this could be due to the fact that these isolates are acidocin producers and the primary target of acidocin is pore forming bacteriocin that creates cell membrane channels through the barrel-stave mechanism (Ahmed et al., 2010)
The results revealed that the agar diffusion method was suitable for the study of antimicrobial activity of L. acidophilus strains. This could be explained by the good diffusion of metabolites from L. acidophilus strains in the well method and this may have resulted in the growth inhibition of the pathogenic microorganisms.
It is evident from the results of the measurement of the diameters of zone of inhibition that the metabolites are significantly effective. This could be due to the fact that the metabolites produced by the probiotics include bioactive products such as organic acid, hydrogen peroxide (H2O2) and bacteriocins. Other researchers reported that the cell-free supernatant solution from strains of lactic acid bacteria exhibited antimicrobial activity which prevented the growth of different strains of S. aureus and E. coli (Lavermicocca et al., 2000; Arokiyamary and Sivakumar, 2011). Further, Cheikhyoussef et al. (2007) reported that the principal metabolites of probiotics bacteria are acetic acid and lactic acid in the ratio of 3:2 and these acids are responsible for the consequent drop in pH, which may be sufficient to antagonize many pathogenic bacteria belonging to Gram-positive and Gram-negative class.
In addition, compared with commercial media such as MRS and Rogosa medium, the noni and soya milk media were nontoxic and are suitable for human consumption. The genus Lactobacillus has a long history of safe use and it plays a major role in fermented milk and other food products (Karska-Wysocki et al., 2010). Lactic acid bacteria strain produced the bacteriocin (bactericidal bioactive compounds) and that they are capable of controlling the growth and formation of biofilm of pathogen and they are highly antagonistic to pathogenic microorganism (Ammor et al., 2006).
The growth of pathogenic bacteria, Staphyloccus aureus and Escherichia coli were significantly inhibited by metabolites of L. acidophilus cultured in Morinda citrifolia (noni) juice and Glycine max (soya bean) extract growth media. Metabolites isolated from L. acidophilus cultivated in the media derived from natural products exhibited strong bactericidal property, which could provide novel value added medicinal benefits to human beings. The new media could serve as cheap alternative culture media compared to the presently available commercial ones.
The present study was financially supported by USMs Research Creativity and Management Office (RCMO), USM-RU-PGRS Grant Number: 1001/PFARMASI/843084 and Universiti Sains Malaysia Graduate Assistance Scheme for Financial Aid.
Ahmed, Z., Y. Wang, Q. Cheng and M. Imran, 2010. Lactobacillus acidophilus bacteriocin, from production to their application. Afr. J. Biotechnol., 9: 2843-2850.
Amin, M., M. Jorfi, A.D. Khosravi, A.R. Samarbafzadeh and A.F. Sheikh, 2009. Isolation and identification of Lactobacillus casei and Lactobacillus plantarum from plants by PCR and detection of their antibacterial activity. J. Biol. Sci., 9: 810-814.
Ammor, S., G. Tauveron, E. Dufour and I. Chevallier, 2006. Antibacterial activity of lactic acid bacteria against spoilage and pathogenic bacteria isolated from the same meat small-scale facility: 1-Screening and characterization of the antibacterial compounds. Food Control, 17: 454-461.
Arokiyamary, A. and P.K. Sivakumar, 2011. Antibacterial activity of bacterocin producing Lactobacillus sp., isolated from traditional milk products. Curr. Bot., 2: 5-8.
Atlas, R.M., 1997. Handbook of Microbiological Media. 2nd Edn., CRC Press, Boca Raton, Florida.
Bali, V., P.S. Panesar and M.B. Bera, 2011. Isolation, screening and evaluation of antimicrobial activity of potential bacteriocin producing lactic acid bacteria isolate. Microbiol. J., 1: 113-119.
Bhilabutra, W., T. Techowisan, J.F. Peberdy and S. Lumyong, 2007. Antimicrobial activity of bioactive compounds from Periconia siamensis CMUGE015. Res. J. Microbiol., 2: 749-755.
Bhunia, A.K., M.C. Johnson, B. Ray and N. Kalchayanand, 1991. Mode of action of pediocin AcH from Pediococcus acidilactis H on sensitive bacterial strains. J. Applied Bacteriol., 70: 25-33.
Chantharasophon, K., T. Warong, P. Mapatsa and V. Leelavatcharamas, 2011. High potential probiotic Bacillus species from gastro-intestinal tract of Nile Tilapia (Oreochromis niloticus). Biotechnology, 10: 498-505.
Cheikhyoussef, A., N. Pogori and H. Zhang, 2007. Study of the inhibition effects of Bifidobacterium supernatants towards growth of Bacillus cereus and Escherichia coli. Int. J. Dairy Sci., 2: 116-125.
Critchfield, J.W., S. van Hemert, M. Ash, L. Mulder and P. Ashwood, 2011. The potential role of probiotics in the management of childhood autism spectrum disorders. Gastroenterol. Res. Pract., 10.1155/2011/161358
De Man, J.C., M. Rogosa and M.E. Sharpe, 1960. A medium for the cultivation of Lactobacilli. J. Applied Bacteriol., 23: 130-135.
Douglas, L.C. and M.E. Sanders, 2008. Probiotics and prebiotics in dietetics practice. J. Am. Dietetic Assoc., 108: 510-521.
Eklund, T., 1989. Organic Acids and Esters. In: Mechanisms of Action of Food Preservation Procedures, Gould, G.W. (Ed.). Elsevier Applied Sciences, New York, USA., pp: 196-200.
Fooks, L.J. and G.R. Gibson, 2002. In vitro investigations of the effect of probiotics and prebiotics on selected human intestinal pathogens. FEMS Microbiol. Ecol., 39: 67-75.
Gan, B.S., J. Kim, G. Reid, P. Cadieux and J.C. Howard, 2002. Lactobacillus fermentum RC-14 inhibits Staphylococcus aureus infection of surgical implants in rats. J. Infect. Dis., 185: 1369-1372.
Gharaei-Fathabad, E. and M. Eslamifar, 2011. Isolation and applications of one strain of Lactobacillus paraplantarum from tea leaves (Camellia sinensis). Am. J. Food Technol., 6: 429-434.
Hartemink, R., V.R. Domenech and F.M. Rombouts, 1997. LAMVAB: A new selective medium for the isolation of lactobacilli from faeces. J. Microbiol. Methods, 29: 77-84.
Heller, K.J., 2001. Probiotic bacteria in fermented foods: Product characteristics and starter organisms 1'2'3. Am. J. Clin. Nutr., 73: 374S-379S.
Hirazumi, A., E. Furusawa, S.C. Chou and Y. Hokama, 1996. Immunomodulation contributes to the anticancer activity of Morinda citrifolia (Noni) fruit juice. Proc. Western Pharmacol. Soc., 39: 7-9.
Hung, A.T.Y., T.M. Su, C.W. Liao and J.J. Lu, 2008. Effect of probiotic combination fermented soybean meal on growth performance, lipid metabolism and immunological response of growing-finishing pigs. Asian J. Anim. Vet. Adv., 3: 431-436.
Karska-Wysocki, B., M. Bazo and W. Smoragiewicz, 2010. Antibacterial activity of Lactobacillus acidophilus and Lactobacillus casei against methicillin-resistant Staphylococcus aureus (MRSA). Microbiol. Res., 165: 674-686.
Lavermicocca, P., F. Valerio, A. Evidente, S. Lazzaroni, A. Corsetti and M. Gobetti, 2000. Purification and characterization of novel antifungal compounds from the sourdough Lactobacillus plantarum strain 21B. Applied Environ. Microbiol., 66: 4084-4090.
Mach, T., 2006. Clinical usefulness of probiotics in inflammatory bowel diseases. J. Physiol. Pharmacol., 57: 23-33.
Mitsuoka, T., 1978. Intestinal Bacteria and Health: An Introductory Narrative. Harcourt Brace Jovanovich, Inc., Tokyo, Japan, pp: 25-31.
NCCAM, 2008. Get the facts: An introduction to probiotics. National Center for Complementary and Alternative Medicine, U.S. National Institutes of Health. http://www.intute.ac.uk/cgi-bin/fullrecord.pl?handle=20070127-100910.
Naidu, A.S., W.R. Bidlack and R.A. Clemens, 1999. Probiotic spectra of Lactic Acid Bacteria (LAB). Crit. Rev. Food Sci. Nutr., 39: 113-126.
Naveena, B.J., M. Altaf, K. Bhadriah and G. Reddy, 2005. Selection of medium components by Plackett-Burman design for production of L(+) lactic acid by Lactobacillus amylophilus GV6 in SSF using wheat bran. Bioresour. Technol., 96: 485-490.
O'Mahony, L., J. McCarthy, P. Kelly, G. Hurley and F. Luo et al., 2005. Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles. Gastroenterology, 128: 541-551.
Pitt, W.M., T.J. Harden and R.R. Hull, 2000. Behavior of Listeria monocytogenes in pasteurized milk during fermentation with lactic acid bacteria. J. Food Prot., 63: 916-920.
Reid, G., 2008. Probiotic Lactobacilli for urogenital health in women. J. Clin. Gastroenterol., 42: S234-S236.
Rogosa, M., J.A. Mitchell and R.F. Wiseman, 1951. A selective medium for the isolation and enumeration of oral and feacal lactobacilli. J. Bacteriol., 62: 132-133.
Saavedra, J.M., 2001. Clinical applications of probiotic agents. Am. J. Clin. Nutr., 73: 1147S-1151S.
Savadogo, A., C.A.T. Quattara, I.H.N. Bassole and A.S. Tarore, 2004. Antimicrobial activity of lactic acid bacteria isolated from Burkina Faso fermented milk. Pak. J. Nutr., 3: 174-179.
Saxelin, M., H. Rautelin, S. Salminen and P.H. Makela, 1996. Safety of commercial products with viable Lactobacillus strains. Infect Dis. Clin. Pract., 5: 331-335.
Schillinger, U. and F. Lucke, 1989. Antibacterial activity of Lactobacillus sake isolated from meat. Applied Environ. Microbiol., 55: 1901-1906.
Schillinger, U. and F.K. Lucke, 1989. Antibacterial activity of Lactobacillus sake isolated from meat. Applied Environ. Microbiol., 55: 1901-1906.
Selvam, P., N. Murugesh, M. Witvrouw, E. Keyaerts and J. Neyts, 2009. Studies of antiviral activity and cytotoxicity of Wrightia tinctoria and Morinda citrifolia. Indian J. Pharm. Sci., 71: 670-672.
Shahravy, A., F. Tabandeh, B. Bambai, H.R. Zamanizadeh and M. Mizani, 2012. Optimization of probiotic Lactobacillus casei ATCC 334 production using date powder as carbon source. Chem. Ind. Chem. Eng. Q., 18: 273-282.
Singh, Y.N., T. Ikahihifo, M. Panuve and C. Slatter, 1984. Folk medicine in tonga: A study on the use of herbal medicines for obstectric and gynacological condition and disorders. J. Ethnopharmacol., 12: 305-325.
Tadesse, G., E. Ephraim and M. Ashenafi, 2005. Assessment of the antimicrobial activity of lactic acid bacteria isolated from Borde and Shamita, traditional Ethiopian fermented beverages, on some food-borne pathogens and effect of growth medium on the inhibitory activity. Internet J. Food Saf., 5: 13-20.
Tharmaraj, N. and N.P. Shah, 2009. Antimicrobial effects of probiotics against selected pathogenic and spoilage bacteria in cheese-based dips. Int. Food Res. J., 16: 261-276.
Toure, R., E. Kheadr, C. Lacroix, O. Moroni and I. Fliss, 2003. Production of antibacterial substances by bifidobacterial isolates from infant stool active against Listeria monocytogenes. J. Applied Microbiol., 95: 1058-1069.
Usman and A. Hosono, 2000. Effect of administration of Lactobacillus gasseri on serum lipids and fecal steroids in hypercholesterolemic rats. J. Dairy Sci., 83: 1705-1711.
Vanderhoof, J.A., 2008. Probiotics in allergy management. J. Pediatric Gastroenterol. Nutr., 47: S38-S40.
Wang, M.Y., G. Anderson, D. Nowicki and J. Jensen, 2008. Hepatic protection by Noni fruit juice against CCl4-induced chronic liver damage in female SD Rats. Plant Foods Hum. Nutr., 63: 141-145.
Yan, F. and D.B. Polk, 2006. Probiotics as functional food in the treatment of diarrhea. Curr. Opin. Clin. Nutr. Metab. Care, 9: 717-721.
Yesillik, S., N. Yildirim, A. Dikici, A. Yildiz and S. Yesillik, 2011. Antibacterial effects of some fermented commercial and homemade dairy products and 0.9% lactic acid against selected foodborne pathogens. Asian J. Anim. Vet. Adv., 6: 189-195.